Lenacapavir, Emcure Pharmaceuticals and HIV
Emcure Pharmaceuticals partners with Gilead Sciences to produce HIV prevention drug Lenacapavir
Emcure Pharmaceuticals has partnered with Gilead Sciences Ireland UC to manufacture and distribute generic lenacapavir for HIV prevention and treatment. This royalty-free agreement focuses on increasing access to the drug in 120 countries,
Increasing Global Access: Emcure's Landmark Agreement on HIV Drug Lenacapavir
Emcure Pharmaceuticals has partnered with Gilead Sciences to produce and distribute generic lenacapavir, an HIV treatment drug. This initiative aims to improve access to HIV prevention and treatment,
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based
Indian pharma firms sign deal to produce, sell generic HIV drug lenacapavir
Indian pharmaceutical companies are set to produce generic versions of lenacapavir, an HIV prevention drug, under agreements with US-based Gilead Sciences to distribute it in 120 resource-limited countries.
Indian pharma firms ink deal with U.S. drug maker Gilead to make, market generic HIV drug lenacapavir
Dr. Reddy's, Hetero, and Mylan partner with Gilead Sciences to manufacture generic lenacapavir for HIV prevention globally.
Investing18h
Emcure Pharmaceuticals Ltd (EMCU)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Emcure Pharma share price jumps over 5% to 52-week high as Kotak initiates coverage with ‘Add’ rating; sees 11% upside
Emcure Pharma stock price is up more than 19% from its listing price and over 56% from its IPO price. The pharma stock has ...
cnbctv1815d
What differentiates Emcure Pharma from most of its peers
Kotak Institutional Equities noted that Emcure is one of the few Indian pharmaceutical majors with no direct exposure to the ...
Pharmabiz3d
Emcure Pharma’s "ACE YOUR HEART" awareness campaign enters Asia Book of Records on World Heart Day
Emcure Pharma’s "ACE YOUR HEART" awareness campaign enters Asia Book of Records on World Heart Day: Our Bureau, Mumbai Monday, September 30, 2024, 17:10 Hrs [IST] Emcure Pharmac ...
Morningstar21d
Emcure Pharmaceuticals Ltd 544210
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
health.economictimes.indiatimes27d
Emcure Pharma brings product range for menopause wellness
Emcure Pharmaceuticals on Thursday said it has launched a product range aimed at supporting women through their menopausal journey. The Arth range of products addresses the challenges faced by ...
India Infoline3d
Emcure Pharmaceuticals Ltd Key Ratios
The allotment of shares was finalised on July 8, and Emcure Pharma shares were scheduled to be listed on the BSE and NSE on July 10.
NDTV27d
Namita Thapar Emcure Pharmaceuticals
As September is observed as the PCOS awareness month, Namita Thapar, the Executive Director of Emcure Pharmaceuticals and 'Shark Tank India' judge, took to Instagram to talk about the disorder ...